Cargando...

ENHANCED AND SELECTIVE KILLING OF CHRONIC MYELOGENOUS LEUKEMIA CELLS WITH AN ENGINEERED BCR-ABL BINDING PROTEIN AND IMATINIB

The oncoprotein Bcr-Abl stimulates pro-survival pathways and suppresses apoptosis from its exclusively cytoplasmic locale, but when targeted to the mitochondrial compartment of leukemia cells, Bcr-Abl was potently cytotoxic. Therefore, we designed a protein construct to act as a mitochondrial chaper...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Constance, Jonathan E., Woessner, David W., Matissek, Karina J., Mossalam, Mohanad, Lim, Carol S.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3529210/
https://ncbi.nlm.nih.gov/pubmed/22957899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp3003539
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!